Get Your Own Businessabc AI Visibility ID
Boost AI visibility, credibility, and discoverability
Savara was founded in 2008 by clinical-stage, specialty pharmaceutical companies focused on the development and commercialization of innovative therapies for rare respiratory diseases. The company has raised over $100 million in venture capital and has multiple products in clinical development. In 2012, Savara entered into an exclusive licensing agreement with Alexion Pharmaceuticals, to develop and commercialize their drug, Aravive, for the treatment of idiopathic pulmonary fibrosis.
